Evidence map›Paper›PMID 40222800›Full record

ReviewAdvances in kidney disease and health2025

Care That Fits: Optimizing Value-Based Care for Acute Kidney Injury Survivors.

Bethany C Birkelo, Erin F Barreto, Edward D Siew

Abstract readReview
In one paragraph

Review in Advances in kidney disease and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bethany C BirkeloDivision of Nephrology and Hypertension, University of Minnesota, Minneapolis, MN. Electronic address: bbirkelo@umn.edu.
Erin F BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, MN.
Edward D SiewDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Tennessee Valley Health Systems (TVHS), Nashville Veterans Affairs, Nashville, TN.

Funding

The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI ConsortiumU01DK129989 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Javier A. Neyra, Edward D Siew · 2021 to 2026
$4.7M
Beta-lactam individualization for critically ill patientsK23AI143882 · NIAID · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2020 to 2024
$986k
NIAID NIH HHS K23 AI143882NIDDK NIH HHS U01 DK129989
6 · The paper itself

Abstract

Acute kidney injury (AKI) survivors are at risk for substantial adverse outcomes, and the post-AKI setting is a source of high health care utilization. Kidney health is often not prioritized after discharge from an AKI hospitalization and can be complicated by patient and process-related barriers. Improving kidney care for AKI survivors has the potential to improve outcomes, though data on which care models are optimal for this population are lacking. Care models utilized in other patient populations, as well as prior trials of AKI survivor clinics, can provide insight as to how these models could be implemented in the post-AKI setting to improve outcomes in a cost-effective way. Potential care models range on a spectrum from the least specialized, most highly scalable, and cost-effective options, such as patient engagement programs and home health, to more generally accessible models including allied health-driven models, and primary care-embedded programs, to highly specialized and less scalable options, such as nephrology-led survivor clinics. Each has potential applications and limitations in the post-AKI setting. Ongoing studies that incorporate elements of multiple care models may have the most promise to improve value-based care in the care of AKI survivors.

Indexed as

Acute Kidney InjurySurvivorsCost-Benefit AnalysisHumansAcute kidney injuryHealth care deliveryKidney diseasesMultidisciplinary health teamValue-based healthcare

Identifiers

PMID40222800
PMCPMC11999245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.